TenderlineUK
Procurement Intelligence
Search
Find a TenderClosedTender notice
Published 4 Sept 2026, 11:50 BST

Official UK procurement notice

NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping

Official notice

Authority: NHS England (Central government)

Framework agreement2 lotsGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)Yorkshire & Humber (UKE)
+6 moreEast Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Framework ceiling (notional)£432,283,092total for 2 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 19 Oct 2026
Lots 2see the lot list below
Framework period 3 yrsends 31 May 2030 · up to 31 May 2031 with extensions · starts 1 Jun 2027

What is being bought2 lots · detail below

Published requirement description

NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping

Offer Reference number: CM/PHG/25/5738

Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

CM/PHG/25/5738/01 - Oral & Non-Parenteral Products:

CESW (Central/Midlands and Southwest): 1st June 2027 to 31st May 2030 (36 months)

LSNE (London South and Northeast 1st June 2027 to 31st May 2030 (36 months)

NWLN (Northwest and London North): 1st June 2027 to 31st May 2030 (36 months)

CM/PHG/25/5738/02 – Hospital Only (Orals, Non-Parenteral & Housekeeping) Products:

DCE (Central/Midlands) & DSW (Southwest): 1st June 2027 to 30th September 2029 (28 months)

DLS (London South) & DNE (Northeast): 1st June 2027 to 31st May 2028 (12 months)

DNW (Northwest) & DLN (London North): 1st June 2027 to 31st January 2029 (20 months)

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Open framework
Call-offs
every call-off is a further competition among the appointed suppliers
Framework period
3 yrs · up to 4 yrs from 1 Jun 2027
Buyer regions
UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, UKK
Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.

Published description of the framework

Please refer to the ITO Documents for the Operation Description.

Lots and requirements (2)Procurement structure

2 lots · all with a published value
Lot #1CM/PHG/25/5738/01 Orals & Non-Parenteral Products:Renewal 3 yrsSMEPublished value£281,791,000

Potential periods of call-offs under the framework agreement:

CESW (Central/Midlands and Southwest): 1st June 2027 to 31st May 2030 (36 months)

LSNE (London South and Northeast 1st June 2027 to 31st May 2030 (36 months)

NWLN (Northwest and London North): 1st June 2027 to 31st May 2030 (36 months)

Contract period: 1 Jun 2027 – 31 May 2030 (3 yrs) · up to 31 May 2031 with extensionsValue: £281,791,000 exc. VAT · £338,149,200 inc. VAT
Delivery: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East, South WestEligibility: SME eligible
Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 12 months. Total maximum contract length of 48 months
33600000 Pharmaceutical products
Lot #2CM/PHG/25/5738/02 Hospital Only (Orals, Non-Parenteral & Housekeeping)Renewal 2 yrs 4 moSMEPublished value£150,492,092

Potential periods of call-offs under the framework agreement:

DCE (Central/Midlands) & DSW (Southwest): 1st June 2027 to 30th September 2029 (28 months)

DLS (London South) & DNE (Northeast): 1st June 2027 to 31st May 2028 (12 months)

DNW (Northwest) & DLN (London North): 1st June 2027 to 31st January 2029 (20 months)

Contract period: 1 Jun 2027 – 30 Sept 2029 (2 yrs 4 mo) · up to 31 May 2031 with extensionsValue: £150,492,092 exc. VAT · £180,590,510 inc. VAT
Eligibility: SME eligible
Extensions: Option or options to extend (at the authority’s discretion) with a total maximum contract length of 48 months
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Closed
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
4 Sept 2026, 11:50 BST
Last source update
21 Sept 2026, 11:46 BST
Award evaluation window
Submission end – 4 Jan 2027
Authority reference
CM/PHG/25/5738
FTS notice number
2026/S 000-087775
Latest notice
Tender notice (UK4)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+1 moreSouth West (UKK)
Official registry OCID
ocds-h6vhtk-06f21e Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
19 Oct 2026, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional information may be obtained from the abovementioned address.

Tenders must be submitted to the abovementioned address.

Timeline

4 Sept 2026 → 1 Jun 2027 · 8 dates
  1. Planning notice published54 days ago
    4 Sept 2026, 11:50 BST
  2. Market engagement49 days ago
    8 Sept 2026, 23:59 BST

    NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Generic Orals, Non-Parenteral and Housekeeping products to commence on 1st June 2027 for varying dates of up to 36 months with the option to extend to a maximum total contract length of 48 months.

    The purpose of this notice is to inform existing and potential new suppliers of this procurement.

    Useful information for suppliers can be found here: www.england.nhs.uk/medicines-2/medicine… ↗ and the current generics workplan here: www.england.nhs.uk/publication/generics… ↗ .

    Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.

  3. Next notice expected48 days ago
    9 Sept 2026, 23:59 BST
  4. Tender notice published42 days ago
    16 Sept 2026, 13:52 BST
  5. Latest notice published37 days ago
    21 Sept 2026, 11:46 BST
  6. Admission / appointment period ends9 days ago · period end, not a bid countdown
    19 Oct 2026, 13:00 BST
  7. Today
    28 Oct 2026
  8. Award decision expected byin 68 days
    4 Jan 2027, 23:59 GMT
  9. Contract startsin 215 days
    1 Jun 2027, 00:00 BST

Notice history

7 events · 3 releases on Find a Tender · since 4 Sept 2026
  1. Preliminary market engagement notice published
    4 Sept 2026, 11:50 BST
    UK2
  2. Tender notice published
    16 Sept 2026, 13:52 BST
    UK4
  3. Published value updated to £432,283,092
    16 Sept 2026, 13:52 BST
    was £435,634,720
  4. Status changed to active
    16 Sept 2026, 13:52 BST
  5. Procurement method changed
    16 Sept 2026, 13:52 BST
  6. Deadline published: 19 Oct 2026, 13:00 BST
    16 Sept 2026, 13:52 BST
  7. Tender notice published
    21 Sept 2026, 11:46 BST
    UK4
Published amendments (1)

Additional Offer Schedule added for: DXA063 - NINTEDANIB CAPSULES 150MG (60) DXA074 - NINTEDANIB CAPSULES 100MG (60) DMJ037 - DALBAVANCIN POWDER FOR SOLUTION FOR INFUSION VIALS 500MG (1)

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact email

Official documents & specifications (6)

Official links; attachments are not copied

Tender pack and attachments

Notices published for this procedure

  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender
  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender
  • Preliminary market engagement notice planningPreliminary market engagement noticeUK2Preliminary market engagement notice on Find a Tender